CN107098827A - A kind of preparation method of ubenimex intermediate (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid - Google Patents

A kind of preparation method of ubenimex intermediate (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid Download PDF

Info

Publication number
CN107098827A
CN107098827A CN201610094657.8A CN201610094657A CN107098827A CN 107098827 A CN107098827 A CN 107098827A CN 201610094657 A CN201610094657 A CN 201610094657A CN 107098827 A CN107098827 A CN 107098827A
Authority
CN
China
Prior art keywords
acid
compound
preparation
hydroxy
organic base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610094657.8A
Other languages
Chinese (zh)
Inventor
张席妮
资春鹏
周涛
熊志刚
梁劲
泮廷廷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changzhou Ainuo New Rui Pharmaceutical Co Ltd
Original Assignee
Changzhou Ainuo New Rui Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changzhou Ainuo New Rui Pharmaceutical Co Ltd filed Critical Changzhou Ainuo New Rui Pharmaceutical Co Ltd
Priority to CN201610094657.8A priority Critical patent/CN107098827A/en
Publication of CN107098827A publication Critical patent/CN107098827A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/16Preparation of optical isomers
    • C07C231/20Preparation of optical isomers by separation of optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides one kind and ubenimex intermediate (2S is prepared as resolution reagent using organic base, 3R) the method for the phenylbutyric acid of 3 acetylamino, 2 hydroxyl 4, wherein organic base are selected from the naphthalene ethylamines of S 1, (S) 1 (2 naphthyl) ethamine, L benzene glycinol, L phenylalaninols.Ubenimex intermediate purity prepared by the present invention is good, high income, simple to operate, favorable reproducibility, is suitable for industrialized production.

Description

A kind of preparation method of ubenimex intermediate (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid
Technical field
The present invention relates to organic chemistry filed, and in particular to a kind of ubenimex intermediate (2S, 3R) -3- The preparation method of acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid.
Background technology
Ubenimex (Ubenimex), chemical name is N- [(2S, 3R) -4- phenyl -3- amino -2- hydroxyls Base butyryl]-L-Leu, structural formula is as follows:
Ubenimex is a kind of antineoplastic of peptides, and it is H.Umezawa (US 4052449) etc. What people had found from the zymotic fluid of the netted streptomycete of olive, it can promote organism immune response and suppression Aminopeptidase B and leucine aminopeptidase.
Clinical studies show, ubenimex is the cytotoxic activity for suppressing antineoplastic by improving, So as to realize its curative effect in treatment of cancer.This product is used for the chemotherapy of tumor patient, the auxiliary of radiation The disease such as treatment and senile immunodeficiency.Indication include leukaemia, multiple bone marrow cancer, RAEB, and other body knurls.
Ubenimex it is complicated, contain 3 chiral centres, it is different in the presence of 7 solids in theory How structure body, therefore, ensure to properly form 3 chiral centres, and optical purity meets quality and wanted Ask, be the top priority for synthesizing ubenimex.
Journal of Antibiotics, 1983,36 (6):It is beautiful that 659-699 reports a practical black benzene Sigong skill, including using acetophenone as raw material, according to this through bromination, amination, acetylation, aldol condensation, Black benzene is made in hydro-reduction, fractionation, deacetylation, amido protecting, amide condensed and deprotection reaction Department of U.S..Wherein, resolution reaction use S-1- phenyl ethylamines for resolution reagent to racemic modification (chemical combination Thing 1) split, selectively obtain ubenimex intermediate (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxyls -4- Phenylbutyric acid, but the product of high-optical-purity that this resolution process can not be stably obtained, and yield is low, It is unfavorable for industrialized production.
Patent CN101891647 A are disclosed using 1B, L-arginine, L-Histidine pair The method that compound 1 is split, obtains (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxyl -4- benzene of high-purity Base butyric acid, but this method needs progress to be repeatedly beaten purifying and crystallize, and complex operation is unfavorable for industry Metaplasia is produced.
Therefore, find in the middle of a kind of ubenimex of viable commercial method to prepare high-optical-purity Body (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid is necessary.
The content of the invention
The purpose of the present invention be improved in view of the shortcomings of the prior art there is provided one kind it is more stable, pure Degree is high, ubenimex intermediate (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid of favorable reproducibility Preparation method.Using suitable organic base as resolution reagent, from racemic modification (compound 1) In isolated (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid (compound 1a), wherein having Machine alkali is selected from S-1- naphthalene ethylamines, (S) -1- (2- naphthyls) ethamine, L- benzene glycinol, L- phenylalaninols.Its Middle compound 1 is by enantiomter (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid (compounds 1a) constituted with (2R, 3S) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid (compound 1b).
Specifically comprise the steps of:
1) compound 1 and organic base are mixed into salt in a solvent.
2) by step 1) in obtained mixture cool, make salt crystallization precipitation, separation is obtained Compound 1a and organic base salt.
3) by step 2) in obtained by salt be dissolved in the aqueous solution, add appropriate acid, make compound 1a is free to be separated out, and separation obtains (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxyls -4- of high-purity Phenylbutyric acid.
Further, step 1) described in solvent be selected from C1~C10Alcohols, esters, ketone, ethers, One or more in nitrile, aromatic hydrocarbons and alkane.
Further, step 1) described in the mol ratio of compound 1 and organic base be 1:0.2~1:10.0, It is preferred that 1:0.5~1:2.The weight ratio of compound 1 and solvent is 1:1~1:100, preferably 1:5~1:50.
Also, step 1) in compound 1 with the temperature range that organic base is mixed in a solvent be 0~150 DEG C, It is preferred that 20~120 DEG C.Step 2) in the cooling scope of mixture be -20~50 DEG C, preferably 0~40 DEG C. Step 3) described in acid be Bronsted acid.
Using the technology of the present invention, using selected from S-1- naphthalene ethylamines, (S) -1- (2- naphthyls) ethamine, L- benzene Glycinol, the organic base of L- phenylalaninols are split for resolving agent, can disposably obtain high-purity Ubenimex intermediate (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid, without crystallizing again, Optical purity more than 99.5%, yield more than 35%, not only increases production capacity, while also more green Environmental protection.Therefore, this method is easy to operate, favorable reproducibility, environmental protection, is more suitable for industrialization Production.
Embodiment
Below in conjunction with specific embodiment, the invention will be further described, but protection scope of the present invention is not It is limited by the following examples.
1a optical purity is detected with HPLC in embodiment, and provides area percent.
Liquid-phase condition:
Chromatographic column:The Chiralpak AY-H (250*4.6mm, 5 μm) of Daicel chemical company
Mobile phase:N-hexane:Isopropanol:Trifluoroacetic acid=60%:40%:0.1%
Sample preparation:50mg samples are dissolved in 100ml mobile phases
Sample size:10μl
Flow velocity:1ml/min
Column temperature:35℃
Detection wavelength:220nm.
Embodiment 1
(1.8 grams) of compound 1 (2.4 grams) and S-1- naphthalene ethylamines are added in ethanol (10 milliliters), 60 DEG C of stirring dissolved clarifications.Above-mentioned solution is cooled to 25 DEG C, 1.5 grams of white solid is filtrated to get, is The S-1- naphthalene ethylamine salt of (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid, water is added to by this salt In solution (10 milliliters), dissolved clarification is stirred, reagent hydrochloric acid (2 milliliters) is added, stirring separates out solid, Separation, obtains 0.85 gram of (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyls butyric acid, yield 35.4%, ee Value 99.8%.
Embodiment 2
By (1.8 grams) of compound 1 (2.4 grams) and S-1- naphthalene ethylamines add ethanol (10 milliliters) and In acetonitrile (3 milliliters), 60 DEG C of stirring dissolved clarifications.Above-mentioned solution is cooled to 25 DEG C, is filtrated to get white Color solid, is the S-1- naphthalene ethylamine salt of (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid, will This salt is added in the aqueous solution (10 milliliters), stirs dissolved clarification, adds reagent hydrochloric acid (2 milliliters), Stirring separates out solid, and separation obtains 0.89 gram of (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyls butyric acid, Yield 37.1%, ee values 99.6%.
Embodiment 3
By (1.8 grams) addition tetrahydrofurans (20 of compound 1 (2.4 grams) and (S) -1- (2- naphthyls) ethamine Milliliter) in, 60 DEG C of stirring dissolved clarifications.Above-mentioned solution is cooled to 25 DEG C, white solid is filtrated to get, As the S-1- naphthalene ethylamine salt of (2S, 3R) -3- acetylaminohydroxyphenylarsonic acids 2- hydroxy-4-phenyl butyric acid, this salt is added Into the aqueous solution (10 milliliters), dissolved clarification is stirred, reagent hydrochloric acid (2 milliliters) is added, stirring is separated out Solid, separation, obtains 0.88 gram of (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyls butyric acid, yield 36.7%, Ee values 99.6%.
Embodiment 4
By (1.8 grams) of compound 1 (2.4 grams) and S-1- naphthalene ethylamines add ethanol (10 milliliters) and In acetone (3 milliliters), 60 DEG C of stirring dissolved clarifications.Above-mentioned solution is cooled to 25 DEG C, is filtrated to get white Color solid, is the S-1- naphthalene ethylamine salt of (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid, will This salt is added in the aqueous solution (10 milliliters), stirs dissolved clarification, adds reagent hydrochloric acid (2 milliliters), Stirring separates out solid, and separation obtains 0.89 gram of (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyls butyric acid, Yield 37.1%, ee values 99.6%.
Embodiment 5
(1.8 grams) of compound 1 (2.4 grams) and L- benzene glycinol are added into isopropanol (10 milliliters) In isopropyl acetate (3 milliliters), 60 DEG C of stirring dissolved clarifications.Above-mentioned solution is cooled to 25 DEG C, mistake Filter obtains white solid, is the S-1- naphthalene second of (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid Amine salt, this salt is added in the aqueous solution (10 milliliters), stirs dissolved clarification, adds reagent hydrochloric acid (2 Milliliter), stirring separates out solid, and separation obtains (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid 0.87 gram, yield 36.3%, ee values 99.7%.
Embodiment 6
(1.8 grams) of compound 1 (2.4 grams) and L- phenylalaninols are added into isopropanol (20 milliliters) In toluene (5 milliliters), 60 DEG C of stirring dissolved clarifications.Above-mentioned solution is cooled to 25 DEG C, is filtrated to get White solid, is the S-1- naphthalene ethylamine salt of (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid, This salt is added in the aqueous solution (10 milliliters), dissolved clarification is stirred, reagent hydrochloric acid (2 milliliters) is added, Stirring separates out solid, and separation obtains 0.87 gram of (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyls butyric acid, Yield 36.3%, ee values 99.6%.

Claims (7)

1. a kind of preparation side of ubenimex intermediate (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid Method, it is characterised in that using organic base as resolution reagent, from racemic modification (compound 1) Isolated (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid (compound 1a).Described Organic base is selected from S-1- naphthalene ethylamines, (S) -1- (2- naphthyls) ethamine, L- benzene glycinol, L- phenylalaninols. Described compound 1 is by enantiomter (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid (compound 1a) and (2R, 3S) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid (compound 1b) structure Into.
2. preparation method according to claim 1, it is characterised in that comprise the steps of:
1) compound 1 and organic base are mixed into salt in a solvent.
2) by step 1) in obtained mixture cool, make salt crystallization precipitation, separation is obtained Compound 1a and organic base salt.
3) by step 2) in obtained by salt be dissolved in the aqueous solution, add appropriate acid, make compound 1a is free to be separated out, and separation obtains (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxyls -4- of high-purity Phenylbutyric acid.
3. preparation method according to claim 2, it is characterised in that step 1) described in solvent choosing From C1~C10Alcohols, esters, ketone, ethers, nitrile, aromatic hydrocarbons and alkane in one kind or many Kind.
4. preparation method according to claim 2, it is characterised in that step 1) described in compound 1 is 1 with the mol ratio of organic base:0.2~1:10.0, preferably 1:0.5~1:2.Compound 1 and the weight of solvent Amount is than being 1:1~1:100, preferably 1:5~1:50.
5. preparation method according to claim 1, it is characterised in that step 1) in compound 1 with having The temperature range that machine alkali is mixed in a solvent is 0~150 DEG C, preferably 20~120 DEG C.
6. preparation method according to claim 1, it is characterised in that step 2) in mixture cooling Scope is -20~50 DEG C, preferably 0~40 DEG C.
7. preparation method according to claim 1, it is characterised in that step 3) described in acid be matter Sub- acid.
CN201610094657.8A 2016-02-19 2016-02-19 A kind of preparation method of ubenimex intermediate (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid Pending CN107098827A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610094657.8A CN107098827A (en) 2016-02-19 2016-02-19 A kind of preparation method of ubenimex intermediate (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610094657.8A CN107098827A (en) 2016-02-19 2016-02-19 A kind of preparation method of ubenimex intermediate (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid

Publications (1)

Publication Number Publication Date
CN107098827A true CN107098827A (en) 2017-08-29

Family

ID=59658718

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610094657.8A Pending CN107098827A (en) 2016-02-19 2016-02-19 A kind of preparation method of ubenimex intermediate (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid

Country Status (1)

Country Link
CN (1) CN107098827A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109115914A (en) * 2018-10-03 2019-01-01 淮安安莱生物科技有限公司 A kind of efficient liquid-phase chromatography method separating Ramosetron HCl and its S type enantiomter
CN109115913A (en) * 2018-10-03 2019-01-01 淮安安莱生物科技有限公司 A kind of HPLC method based on conventional phenyl chromatography post separation Ramosetron HCl He its S type enantiomter
CN115594606A (en) * 2022-12-16 2023-01-13 成都傲科新技术有限责任公司(Cn) Asymmetric synthesis method of threo-2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109115914A (en) * 2018-10-03 2019-01-01 淮安安莱生物科技有限公司 A kind of efficient liquid-phase chromatography method separating Ramosetron HCl and its S type enantiomter
CN109115913A (en) * 2018-10-03 2019-01-01 淮安安莱生物科技有限公司 A kind of HPLC method based on conventional phenyl chromatography post separation Ramosetron HCl He its S type enantiomter
CN109115914B (en) * 2018-10-03 2021-06-04 四川中科微纳科技有限公司 High performance liquid chromatography method for separating ramosetron hydrochloride and S-type enantiomer thereof
CN109115913B (en) * 2018-10-03 2021-08-06 济南迪安医学检验中心有限公司 HPLC method for separating ramosetron hydrochloride and S-type enantiomer thereof based on conventional phenyl chromatographic column
CN115594606A (en) * 2022-12-16 2023-01-13 成都傲科新技术有限责任公司(Cn) Asymmetric synthesis method of threo-2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid

Similar Documents

Publication Publication Date Title
CN107098827A (en) A kind of preparation method of ubenimex intermediate (2S, 3R) -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid
KR100666423B1 (en) Process for the preparation of 2r-2-propyloctanoic acid
US7449589B2 (en) Process for purifying (-)-Δ9-trans-tetrahydrocannabinol
JP7186460B2 (en) Co-crystal of 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
CN103467475A (en) Purification method for 1, 8-cineole
US10752571B2 (en) Method for purification of 4-hydroxyacetophenone
CN110642706B (en) Preparation method of high-purity phenoxyethanol
CA2542788C (en) Process for producing bicalutamide and method of purifying intermediate thereof
US8461347B2 (en) Process for preparing form A of atazanavir sulfate
TW200909406A (en) Process for enantioselectively preparing optically active 4-hydroxy-2,6,6-trimethylcyclohex-2-enone derivatives
US20120108554A1 (en) PROCESS FOR PREPARING HIGH PURITY 1alpha-HYDROXY VITAMIN D2
CN113024434A (en) Preparation method of brivaracetam intermediate
CN113735874B (en) Method for selectively extracting and separating artemisinin/arteannuin by using hydrophobic ionic liquid
CN110668922B (en) Refining method of musk camphor
US20210395197A1 (en) Crystalline form of sofpironium bromide and preparation method thereof
US20040176637A1 (en) Process for preparation of 2-chlorophenylglycine derivatives and enantiomerically separation
JPH08198836A (en) Production of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
CN111484418B (en) Preparation method of 4-amino-2-cyclopentene-1-methanol hydrochloride
JP5092289B2 (en) Process for producing optically active N-tert-butylcarbamoyl-L-tert-leucine
WO2007080470A2 (en) A method for the purification of levetiracetam
EP3068746B1 (en) Process for the preparation of enantiomerically pure 1-aminoindan
EP1785412A1 (en) Tramadol recovery process
KR101916956B1 (en) Novel Solid form of Ticagrelor and methods of preparing therof
CN104926699B (en) A kind of preparation method of high-optical-purity tamsulosin hydrochloride
CN105985408A (en) Purifying method for carfilzomib

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170829